Table 2 Case and age- and sex-matched control data in the derivation cohort.
From: ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population
|  | Control (n = 2400) | NAFLD (n = 2400) | P |
|---|---|---|---|
Age (years) | 48.0 ± 10.2 | 48.1 ± 10.1 | 0.798 |
Sex (male%) | 73.7 | 73.7 | 1.000 |
Height (cm) | 166.54 ± 7.83 | 166.65 ± 7.91 | <0.001 |
Weight (kg) | 64.03 ± 9.87 | 72.57 ± 10.91 | <0.001 |
BMI (kg/m2) | 23.04 ± 2.67 | 26.02 ± 2.95 | <0.001 |
Waist circumference (cm) | 82.32 ± 8.25 | 90.32 ± 8.21 | <0.001 |
SBP (mmHg) | 125.66 ± 17.63 | 132.93 ± 17.63 | <0.001 |
DBP (mmHg) | 76.80 ± 11.57 | 81.68 ± 10.96 | <0.001 |
Heart rate (per min) | 73.05 ± 10.47 | 75.36 ± 10.71 | <0.001 |
Hemoglobin (g/L) | 148.19 ± 15.07 | 151.32 ± 15.06 | <0.001 |
Platelet count (×109) | 200.57 ± 48.61 | 211.66 ± 52.79 | <0.001 |
White blood cell count (×109) | 5.76 ± 1.50 | 6.32 ± 1.52 | <0.001 |
Neutrophil count (×109) | 3.30 ± 1.15 | 3.60 ± 1.16 | <0.001 |
Albumin (g/L) | 46.18 ± 3.17 | 46.65 ± 3.07 | <0.001 |
Globulin (g/L) | 25.98 ± 3.35 | 26.53 ± 3.44 | <0.001 |
Uric acid (μmol/L) | 330.35 ± 82.46 | 367.47 ± 87.45 | <0.001 |
Fasting plasma glucose (mmol/L) | 4.88 ± 0.84 | 5.31 ± 1.31 | <0.001 |
Triglycerides (mmol/L) | 1.33 ± 0.89 | 2.06 ± 1.58 | <0.001 |
Total cholesterol (mmol/L) | 4.69 ± 0.86 | 4.89 ± 0.89 | <0.001 |
LDL-C (mmol/L) | 2.60 ± 0.65 | 2.68 ± 0.68 | <0.001 |
VLDL-C (mmol/L) | 0.81 ± 0.42 | 1.08 ± 0.61 | <0.001 |
HDL-C (mmol/L) | 1.29 ± 0.31 | 1.14 ± 0.28 | <0.001 |
AFU (IU/L) | 26.61 ± 7.56 | 28.56 ± 7.90 | <0.001 |
ALT (IU/L) | 21.49 ± 21.31 | 30.39 ± 22.58 | <0.001 |
AST (IU/L) | 21.64 ± 11.57 | 24.10 ± 11.27 | <0.001 |
ALT/AST ratio | 0.95 ± 0.33 | 1.20 ± 0.43 | <0.001 |
GGT (IU/L) | 32.66 ± 68.24 | 46.15 ± 48.14 | <0.001 |
Cholinesterase (IU/L) | 8510 ± 1616 | 9474 ± 1541 | <0.001 |
ALP (IU/L) | 66.66 ± 19.31 | 68.93 ± 19.91 | <0.001 |
AFP (ng/ml) | 3.03 ± 1.88 | 2.90 ± 1.54 | 0.007 |
